MARKET

NBIX

NBIX

Neurocrine Biosciences Inc
NASDAQ
177.40
+4.40
+2.54%
Opening 15:12 07/21 EDT
OPEN
174.77
PREV CLOSE
173.00
HIGH
178.94
LOW
174.50
VOLUME
758.55K
TURNOVER
--
52 WEEK HIGH
181.18
52 WEEK LOW
122.14
MARKET CAP
17.84B
P/E (TTM)
27.29
1D
5D
1M
3M
1Y
5Y
1D
Alnylam Stock And 2 US Health Care Names With Earnings In Focus
Simply Wall St · 22h ago
Top buy and sell ideas within each sector – Oppenheimer
Seeking Alpha · 1d ago
Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus
NASDAQ · 1d ago
Weekly Report: what happened at NBIX last week (0713-0717)?
Weekly Report · 1d ago
Neurocrine Biosciences (NBIX) Stock Looks Reasonable At Today’s Price
Simply Wall St · 2d ago
Is Neurocrine Biosciences (NBIX) Still Undervalued Or Does Its P E Leave Little Upside?
Simply Wall St · 3d ago
Neurocrine Is Maintained at Overweight by Wells Fargo
Dow Jones · 4d ago
Wells Fargo Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $200
Benzinga · 4d ago
More
About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It is engaged in discovering, developing, and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine, and immunological disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its first-in-class commercial portfolio includes INGREZZA (valbenazine) and CRENESSITY (crinecerfont). It also offers VYKAT XR (diazoxide choline) extended-release tablets, for the treatment of hyperphagia in adults and pediatric patients four years of age and older with Prader-Willi syndrome (PWS). Its pipeline includes direclidine / (M4 Agonist), osavampator॥ / (AMPA PAM) and others.

Webull offers Neurocrine Biosciences, Inc stock information, including NASDAQ: NBIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBIX stock methods without spending real money on the virtual paper trading platform.